BioVersys Logo

BioVersys

🇨🇭
BIOV
CH0210362643

BioVersys AG is a Swiss biopharmaceutical company based in Basel. It develops novel antibiotics and compounds targeting antimicrobial resistance, addressing hard-to-treat bacterial infections such as tuberculosis and hospital-acquired infections.

Next Quarterly Earnings

Wednesday, September 9, 2026
CW 37
Pre-Market
In 13 days

Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

Currently in quiet period until September 9, 2026

Stock Price

Frequently asked questions

When will BioVersys report its next quarterly earnings?

BioVersys is scheduled to report its next quarterly earnings on 09/09/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

How do I add the BioVersys earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q2 2026
Estimate:-CHF 1.71
Actual:

Company Information

Name
BioVersys
Ticker Symbol
BIOV
ISIN
CH0210362643
Country
🇨🇭
Switzerland
Sector
More Financial Information